PRIMED

  • Posted on: 24 August 2017
  • By: admin

Window of opportunity study for patients with resectable squamous cell carcinoma of the oral cavity who are considered suitable for curative-intent surgical resection, with pre-operative mocetinostat and durvalumab. Eligible Tumour Type(s): squamous cell carcinoma of the oral cavity

Sponsor: 
In-House
NCT#: 
NCT02993991
Eligible Tumour Types: 
Squamous Cell Carcinoma of the Oral Cavity
Recruiting Status: 
Closed Recruiting
Principal Investigator: 
Lillian Siu